CM
MLAB icon

Castleark Management’s Mesa Laboratories MLAB Stock Holding History

Castleark Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-28,451
Closed -$6.43M – 368
2020
Q1 		$6.43M Buy
28,451
+1,130
+4% +$279K 0.38% 74
2019
Q4 		$6.81M Sell
27,321
-4,954
-15% -$1.16M 0.27% 124
2019
Q3 		$7.67M Buy
+32,275
New +$7.46M 0.31% 117

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Castleark Management's MLAB Position: Q2 2020 in Review

Castleark Management sold out of Mesa Laboratories (MLAB) in Q2 2020, closing a stake of 28,451 shares — an estimated $6.43M sold.

Castleark Management first reported a position in MLAB in Q3 2019 and held it in 3 quarters. The position peaked at $7.67M in Q3 2019. 169 funds tracked by Wall St. Rank hold MLAB as of Q2 2020.

  • Castleark Management reported no remaining Mesa Laboratories position as of Q2 2020 after selling out during the quarter.
  • Castleark Management sold 28,451 Mesa Laboratories shares in Q2 2020, an estimated $6.43M.
  • Castleark Management first reported a position in Mesa Laboratories in Q3 2019 and held it in 3 quarters.
  • Castleark Management's Mesa Laboratories position peaked at $7.67M in Q3 2019.
  • 169 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2020.

Based on Castleark Management's 13F filing for Q2 2020, filed 14 Aug 2020.